For the pharmaceutical industry big data and advanced analytics including AI has triggered a fundamental shift within the innovation paradigm. There are significant opportunities in the field of artificial intelligence to transform the business – from the way we develop drugs to the way we engage with our stakeholders. Artificial intelligence holds the potential to drive unprecedented productivity improvements and better outcomes across the value chain as well as to improve our value proposition in creating new offerings and business models.